Aurobindo Pharma to Attend JM Financial Annual India Conference
Aurobindo Pharma Ltd 路 Intimation 路 09 Nov 2026, 8:04 pm
Aurobindo Pharma to Attend JM Financial Annual India Conference Aurobindo Pharma has notified exchanges that its officials will participate in the India Xchange 2026 - JM Financial Annual India Conference on 16th Nov'26 in Mumbai. The company is scheduled to engage in one-on-one and group investor meetings between 09:00 AM and 05:00 PM IST. The management confirmed that no unpublished price-sensitive information will be discussed during these interactions.
Original exchange filing (PDF)
More announcements from Aurobindo Pharma Ltd
- Intimation of classification of US FDA inspection at Lannet Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company. 路 12 Nov 2026
- Submission of Earning Call Transcript for Q2FY27. 路 11 Nov 2026
- Unit-2 of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company received Establishment Inspection Report from US FDA with classification as "Voluntary Action Indicated". 路 11 Nov 2026
- Intimation of investors / analysts meet to be held on 17.11.2026. 路 09 Nov 2026
- Submission of Financial results for the Quarter and Half year ended September 30, 2026. 路 05 Nov 2026
- Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027. 路 05 Nov 2026
- Transfer of ownership of Auro Pharma LLC, Russia from Auroactive Pharma Private Limited to Auropharm Overseas Limited, Wholly Owned subsidiaries of the Company. 路 05 Nov 2026
- Approved the proposal of Merger of two wholly owned subsidiaries of the Company. 路 05 Nov 2026
